Fulcrum Therapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Fulcrum Therapeutics, Inc. Website Screenshot

http://www.fulcrumtx.com

Fulcrum Therapeutics, Inc. Company Intro

Modulating gene expression to treat the root cause of genetically defined diseases. Learn more about our pipeline and our culture.

Industry

Healthcare

Fulcrum Therapeutics, Inc. Headquaters

26 Landsdowne Street
Cambridge,02139
United States


Fulcrum Therapeutics, Inc. Share price

26 Jan 2021 01:41 GMT

$13.59

-0.21 (-1.52 %)


Fulcrum Therapeutics, Inc. Market cap

$418.249 M


WMC RANKING

2021

Fulcrum Therapeutics, Inc. # 232

Biotechnology

Latest Fulcrum Therapeutics, Inc. News

News 19 Jan 2021

Fulcrum Therapeutics Announces Proposed Public Offering of ...

19, 2021 — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically ...

News 14 Jan 2021

Global Duchenne Muscular Dystrophy Drugs Market Business Outlook with COVID-19 Scenario – Akashi Therapeutics Inc, Antisense Therapeutics Ltd, Beech Tree Labs Inc, Biogen Inc

... Market Business Outlook with COVID-19 Scenario – Akashi Therapeutics Inc, ... Hoffmann-La Roche Ltd, FibroGen Inc, Fulcrum Therapeutics Inc, Galapagos ...

News 14 Jan 2021

Global Duchenne Muscular Dystrophy Drugs Market Business Outlook with COVID-19 Scenario – Akashi Therapeutics Inc, Antisense Therapeutics Ltd, Beech Tree Labs Inc, Biogen Inc

... Market Business Outlook with COVID-19 Scenario – Akashi Therapeutics Inc, ... Hoffmann-La Roche Ltd, FibroGen Inc, Fulcrum Therapeutics Inc, Galapagos ...


WMC Market Score


WMC Market to Revenue Score


Fulcrum Therapeutics, Inc. Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Fulcrum Therapeutics, Inc. USD $4,598 $74,912 $-69,222 $4,182M 232
Regeneron Pharmaceuticals, Inc. USD $9,243,500 $5,152,600 $3,156,000 $584,960B 1
Alexion Pharmaceuticals, Inc. USD $5,862,400 $2,588,400 $956,600 $352,840B 2
Vertex Pharmaceuticals Incorporated USD $5,991,128 $2,596,854 $2,690,691 $627,500B 3
ALK-Abello A/S USD $3,383,000 $1,831,000 $43,000 $271,200B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Fulcrum Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors



Fulcrum Therapeutics, Inc. Post vs Top 4 Industry Competitors




Fulcrum Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors



Fulcrum Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors



Fulcrum Therapeutics, Inc. WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Fulcrum Therapeutics, Inc. 0.05 1.26 11.27 0 0 0 6.40
Regeneron Pharmaceuticals, Inc. 100 66.54 29.44 100 0 0 100
Alexion Pharmaceuticals, Inc. 63.42 16.37 100 60 0 0 90.05
Vertex Pharmaceuticals Incorporated 64.81 100 8.77 86 0 0 99.30
ALK-Abello A/S 36.60 0 0 0 0 0 0

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries